标题
Do current therapeutic anti-Aβ antibodies for Alzheimer’s disease engage the target?
作者
关键词
Alzheimer’s disease, β-Amyloid, Bapineuzumab, Crenezumab, Solanezumab, Mass spectrometry
出版物
ACTA NEUROPATHOLOGICA
Volume 127, Issue 6, Pages 803-810
出版商
Springer Nature
发表日期
2014-05-06
DOI
10.1007/s00401-014-1290-2
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Oligomers, fact or artefact? SDS-PAGE induces dimerization of β-amyloid in human brain samples
- (2013) Andrew D. Watt et al. ACTA NEUROPATHOLOGICA
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
- (2013) Victor L Villemagne et al. LANCET NEUROLOGY
- Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease
- (2012) Henrik Zetterberg ARCHIVES OF NEUROLOGY
- Solanezumab for the treatment of mild-to-moderate Alzheimer’s disease
- (2012) Bruno P Imbimbo et al. Expert Review of Clinical Immunology
- An Effector-Reduced Anti- -Amyloid (A ) Antibody with Unique A Binding Properties Promotes Neuroprotection and Glial Engulfment of A
- (2012) O. Adolfsson et al. JOURNAL OF NEUROSCIENCE
- Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
- (2012) Reisa Sperling et al. LANCET NEUROLOGY
- Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease–like pathology and cognitive decline
- (2012) Johannes vom Berg et al. NATURE MEDICINE
- Sting of Alzheimer's failures offset by upcoming prevention trials
- (2012) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Resolving controversies on the path to Alzheimer's therapeutics
- (2011) Dennis J Selkoe NATURE MEDICINE
- Testing the Right Target and Right Drug at the Right Stage
- (2011) R. A. Sperling et al. Science Translational Medicine
- Blood-Borne Amyloid- Dimer Correlates with Clinical Markers of Alzheimer's Disease
- (2010) V. L. Villemagne et al. JOURNAL OF NEUROSCIENCE
- 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
- (2010) Juha O Rinne et al. LANCET NEUROLOGY
- Alzheimer's disease: strategies for disease modification
- (2010) Martin Citron NATURE REVIEWS DRUG DISCOVERY
- The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease
- (2009) Kathryn A Ellis et al. INTERNATIONAL PSYCHOGERIATRICS
- Robust Prediction of the MASCOT Score for an Improved Quality Assessment in Mass Spectrometric Proteomics
- (2008) Thomas Koenig et al. JOURNAL OF PROTEOME RESEARCH
- Antibody Capture of Soluble Aβ Does Not Reduce Cortical Aβ Amyloidosis in the PDAPP Mouse
- (2008) Peter Seubert et al. Neurodegenerative Diseases
- The epitope space of the human proteome
- (2008) Lisa Berglund et al. PROTEIN SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now